These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32277525)

  • 1. Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper.
    Heil EL; Aitken SL; Nix DE; Drew R; Rose WE; Davis SL; Justo JA; Fish DN; Pogue JM;
    Pharmacotherapy; 2020 Apr; 40(4):368-371. PubMed ID: 32277525
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure.
    Rhee C; Chiotos K; Cosgrove SE; Heil EL; Kadri SS; Kalil AC; Gilbert DN; Masur H; Septimus EJ; Sweeney DA; Strich JR; Winslow DL; Klompas M
    Clin Infect Dis; 2021 Feb; 72(4):541-552. PubMed ID: 32374861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centers for Medicare and Medicaid Services Measure Stewards' Assessment of the Infectious Diseases Society of America's Position Paper on SEP-1.
    Townsend SR; Rivers EP; Duseja R
    Clin Infect Dis; 2021 Feb; 72(4):553-555. PubMed ID: 32374387
    [No Abstract]   [Full Text] [Related]  

  • 4. Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria?
    Al-Hasan MN; Justo JA
    Clin Infect Dis; 2019 Apr; 68(8):1431. PubMed ID: 30102340
    [No Abstract]   [Full Text] [Related]  

  • 5. Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.
    IDSA Sepsis Task Force
    Clin Infect Dis; 2018 May; 66(10):1631-1635. PubMed ID: 29182749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro B
    Clin Infect Dis; 2020 Sep; 71(6):1361-1364. PubMed ID: 32658968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Diseases Society of America position statement on infectious diseases physicians and hospital pharmacists: comment and editorial.
    Quintiliani R; Ambrose PG; Nicolau DP; Richerson MA; Bui KQ; McNabb J; Nightingale CH; Owens RC
    Clin Infect Dis; 1998 Jul; 27(1):229-31. PubMed ID: 9675493
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
    Drew RH; White R; MacDougall C; Hermsen ED; Owens RC;
    Pharmacotherapy; 2009 May; 29(5):593-607. PubMed ID: 19397466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Past, Present, and Future of the Centers for Medicare and Medicaid Services Quality Measure SEP-1: The Early Management Bundle for Severe Sepsis/Septic Shock.
    Faust JS; Weingart SD
    Emerg Med Clin North Am; 2017 Feb; 35(1):219-231. PubMed ID: 27908335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Society of Infectious Diseases Pharmacists (SIDP) position papers.
    Strayer AH
    Pharm Pract Manag Q; 1996 Jul; 16(2):62-5. PubMed ID: 10161614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious Diseases Society of America position statement on the role of hospital pharmacists.
    Wilson WR; Steckelberg JM; Keating MR
    Clin Infect Dis; 1998 Jul; 27(1):228. PubMed ID: 9675491
    [No Abstract]   [Full Text] [Related]  

  • 12. Sepsis National Hospital Inpatient Quality Measure (SEP-1): Multistakeholder Work Group Recommendations for Appropriate Antibiotics for the Treatment of Sepsis.
    Septimus EJ; Coopersmith CM; Whittle J; Hale CP; Fishman NO; Kim TJ
    Clin Infect Dis; 2017 Oct; 65(9):1565-1569. PubMed ID: 29048513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position statement from infectious diseases society.
    Amin B
    Am J Health Syst Pharm; 1997 Dec; 54(24):2822. PubMed ID: 9428953
    [No Abstract]   [Full Text] [Related]  

  • 14. The essential role of pharmacists in antibiotic stewardship in outpatient care: An official position statement of the Society of Infectious Diseases Pharmacists.
    Blanchette L; Gauthier T; Heil E; Klepser M; Kelly KM; Nailor M; Wei W; Suda K;
    J Am Pharm Assoc (2003); 2018; 58(5):481-484. PubMed ID: 30007508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-rater Agreement for Abstraction of the Early Management Bundle, Severe Sepsis/Septic Shock (SEP-1) Quality Measure in a Multi-Hospital Health System.
    Bauer SR; Gonet JA; Rosario RF; Griffiths LA; Kingery T; Reddy AJ
    Jt Comm J Qual Patient Saf; 2019 Feb; 45(2):108-111. PubMed ID: 30503812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurse Influence in Meeting Compliance With the Centers for Medicare and Medicaid Services Quality Measure: Early Management Bundle, Severe Sepsis/Septic Shock (SEP-1).
    Jorgensen AL
    Dimens Crit Care Nurs; 2019; 38(2):70-82. PubMed ID: 30702476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare.
    Rahmel T; Schmitz S; Nowak H; Schepanek K; Bergmann L; Halberstadt P; Hörter S; Peters J; Adamzik M
    PLoS One; 2020; 15(2):e0228952. PubMed ID: 32050005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Emergency Department Validation of the SEP-3 Sepsis and Septic Shock Definitions and Comparison With 1992 Consensus Definitions.
    Henning DJ; Puskarich MA; Self WH; Howell MD; Donnino MW; Yealy DM; Jones AE; Shapiro NI
    Ann Emerg Med; 2017 Oct; 70(4):544-552.e5. PubMed ID: 28262318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise T; Levine D; Bradley J; Liu C; Mueller B; Pai M; Wong-Beringer A; Rotschafer JC; Rodvold K; Maples HD; Lomaestro BM
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):281-284. PubMed ID: 32659787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.